Mast Cells, T Cells and Abnormal Fibrosis

Overview

Journal Immunol Today

Specialty Allergy & Immunology

Date 2014 Oct 8

PMID 25289983

Citations 8

Authors

H N Claman

Affiliations

Soon will be listed here.

Abstract

Inflamed, fibrotic lesions containing mast cells are characteristic of several clinical disorders and have been noted in graft versus host disease. Here Henry Claman reviews recent insights into the interactions between mast cells, T lymphocytes and fibroblasts which may account for abnormal collagen deposition.

Citing Articles

Mast Cells Are Mediators of Fibrosis and Effector Cell Recruitment in Dermal Chronic Graft-vs.-Host Disease.

Strattan E, Palaniyandi S, Kumari R, Du J, Hakim N, Huang T Front Immunol. 2019; 10:2470.

PMID: 31681336 PMC: 6813249. DOI: 10.3389/fimmu.2019.02470.

Histamine immunohistochemistry is superior to the conventional heparin-based routine staining methodology for investigations of human skin mast cells.

Johansson O, Virtanen M, Hilliges M, Yang Q Histochem J. 1994; 26(5):424-30.

PMID: 8045782 DOI: 10.1007/BF00160055.

Heterogeneity of myofibroblast phenotypic features: an example of fibroblastic cell plasticity.

Schmitt-Graff A, Desmouliere A, Gabbiani G Virchows Arch. 1994; 425(1):3-24.

PMID: 7921410 DOI: 10.1007/BF00193944.

Study on the role of mast cells in the development of liver fibrosis during diethylnitrosamine (DEN) -induced hepatocarcinogenesis in rats.

Xu X, Ruan Y, Wu Z J Tongji Med Univ. 1994; 14(4):193-9.

PMID: 7760426 DOI: 10.1007/BF02897666.

Connective matrix organization in chronic granulomas of experimental paracoccidioidomycosis.

Kerr I, de Oliveira P, Lenzi H Mycopathologia. 1988; 103(1):11-20.

PMID: 3173468 DOI: 10.1007/BF00437216.